Rare but serious concern: GLP-1 drugs carry a boxed warning for medullary thyroid carcinoma risk in animal studies, though no human cases have been conclusively linked to GLP-1 use
A stronger medication effect may also introduce new risks, side effects, or patient-selection concerns
Subacute or chronic progression of symptoms indicating neurological impairment
While autoinjectors have streamlined the process, a learning curve remains, and discomfort persists for many
By Region: Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa
Al igual que la insulina, los anlogos del GLP-1 se utilizan mediante inyecciones subcutneas para tratar la diabetes de tipo 2